Roderick De Greef
CIK 1241181 · Chief Executive Officer · last filed 2026-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLFS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) Delisted | Chief Executive Officer | 439,774 | $38.61 | $16.98M | -$21.97M | 84 | 2026-10-08 |
| PARETEUM Corp (TEUM) Delisted | Director | 18,078 | — | — | $30.4K | 2 | 2017-02-24 |
| PARETEUM Corp (ETAK) Delisted | Director | 176,038 | — | — | $0 | 2 | 2016-04-29 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Director | 860 | — | — | -$2.31M | 12 | 2013-03-08 |
Recent Filings · Page 11 of 13
121 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-11-04 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | — | -$480.9K | EDGAR |
| 2011-09-28 | — | Disp (D) | −50,000 | -$151.7K | |
| 2011-08-10 | — | Grant (A) | +6,614 | $0 | |
| 2011-07-08 | — | Mixed | −42,371 | -$151.5K | |
| 2011-05-27 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-19 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | — | -$131.8K | EDGAR |
| 2011-02-16 | — | Grant (A) | — | $0 | |
| 2010-12-23 | — | Exer (X) | +304,878 | $32.6K | |
| 2010-06-07 | — | Exer (X) | +182,927 | $26.0K | |
| 2010-05-24 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).